Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,077 | 183 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Impulse Dynamics (USA) Inc. | $487.57 | 15 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $416.38 | 33 | $0 (2021) |
| Amgen Inc. | $400.45 | 29 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $397.37 | 30 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $385.66 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $181.53 | 13 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $140.37 | 10 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $113.14 | 7 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $107.25 | 9 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $89.20 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.69 | 7 | Impulse Dynamics (USA) Inc. ($261.69) |
| 2023 | $241.08 | 9 | Impulse Dynamics (USA) Inc. ($225.88) |
| 2021 | $260.69 | 20 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($139.73) |
| 2020 | $375.32 | 28 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($157.12) |
| 2019 | $429.12 | 32 | Amgen Inc. ($138.91) |
| 2018 | $1,012 | 54 | BOSTON SCIENTIFIC CORPORATION ($367.28) |
| 2017 | $497.26 | 33 | Novartis Pharmaceuticals Corporation ($159.96) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $68.00 | General |
| Category: Cardiovascular Device | ||||||
| 08/14/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $30.90 | General |
| Category: Cardiovascular Device | ||||||
| 08/07/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $34.41 | General |
| Category: Cardiovascular Device | ||||||
| 05/02/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Cardiovascular Device | ||||||
| 03/26/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $38.25 | General |
| Category: Cardiovascular Device | ||||||
| 03/14/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $32.12 | General |
| Category: Cardiovascular Device | ||||||
| 02/19/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $32.18 | General |
| Category: Cardiovascular Device | ||||||
| 11/09/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $41.28 | General |
| Category: Cardiovascular Device | ||||||
| 08/08/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Cardiovascular Device | ||||||
| 06/27/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $31.88 | General |
| Category: Cardiovascular Device | ||||||
| 05/09/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $27.91 | General |
| Category: Cardiovascular Device | ||||||
| 04/26/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: Cardiovascular Device | ||||||
| 04/11/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: Cardiovascular Device | ||||||
| 03/13/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $28.90 | General |
| Category: Cardiovascular Device | ||||||
| 02/13/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: Cardiovascular Device | ||||||
| 01/06/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/15/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/25/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: DIABETES | ||||||
| 07/27/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Cardiovascular | ||||||
| 07/22/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/19/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/15/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/01/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 20 | 2,723 | 3,465 | $1.2M | $557,396 |
| 2020 | 21 | 2,473 | 3,199 | $1.1M | $479,031 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2021 | 164 | 164 | $500,261 | $235,556 | 47.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2021 | 164 | 167 | $180,400 | $104,472 | 57.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 291 | 293 | $161,150 | $53,367 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 401 | 452 | $103,068 | $48,737 | 47.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 191 | 764 | $45,840 | $36,375 | 79.4% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 109 | 109 | $40,434 | $19,851 | 49.1% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 37 | 37 | $35,557 | $16,052 | 45.1% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2021 | 200 | 200 | $28,600 | $6,070 | 21.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 422 | 475 | $21,375 | $5,959 | 27.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 285 | 285 | $34,200 | $5,089 | 14.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $10,720 | $4,756 | 44.4% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 21 | 21 | $11,907 | $4,532 | 38.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2021 | 36 | 37 | $4,210 | $3,172 | 75.3% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Office | 2021 | 13 | 13 | $6,347 | $2,857 | 45.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 16 | $5,026 | $2,567 | 51.1% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2021 | 201 | 201 | $13,869 | $2,534 | 18.3% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 28 | 28 | $7,812 | $1,869 | 23.9% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 14 | 46 | $3,220 | $1,524 | 47.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 14 | 41 | $4,920 | $1,483 | 30.1% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2021 | 84 | 84 | $2,520 | $575.41 | 22.8% |
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2020 | 133 | 133 | $408,044 | $186,457 | 45.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2020 | 133 | 172 | $146,300 | $84,679 | 57.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 280 | 280 | $154,000 | $51,051 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 381 | 462 | $101,178 | $38,376 | 37.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 173 | 692 | $41,840 | $32,263 | 77.1% |
About Dr. Michael Herlich, MD
Dr. Michael Herlich, MD is a Cardiovascular Disease healthcare provider based in Haddon Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891748109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Herlich, MD has received a total of $3,077 in payments from pharmaceutical and medical device companies, with $261.69 received in 2024. These payments were reported across 183 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,077).
As a Medicare-enrolled provider, Herlich has provided services to 5,196 Medicare beneficiaries, totaling 6,664 services with total Medicare billing of $1.0M. Data is available for 2 years (2020–2021), covering 41 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Haddon Heights, NJ
- Active Since 05/18/2006
- Last Updated 12/10/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1891748109
Products in Payments
- LifeVest (Device) $416.38
- ENTRESTO (Drug) $397.37
- WATCHMAN (Device) $385.66
- Corlanor (Drug) $295.86
- Optimizer (Device) $261.69
- OPTIMIZER (Device) $225.88
- XARELTO (Drug) $181.53
- Livalo (Drug) $140.37
- BRILINTA (Drug) $108.37
- Repatha (Biological) $104.59
- ELIQUIS (Drug) $101.15
- JARDIANCE (Drug) $79.90
- Vascepa (Drug) $77.44
- PRADAXA (Drug) $33.24
- BYSTOLIC (Drug) $31.87
- MULTAQ (Drug) $29.34
- VERQUVO (Drug) $28.24
- PRALUENT (Drug) $22.94
- CHANTIX (Drug) $22.93
- JUXTAPID (Drug) $15.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Haddon Heights
Dr. Dilip Viswanath, Md, MD
Cardiovascular Disease — Payments: $224,204
Dr. Steven Levi, Md, MD
Cardiovascular Disease — Payments: $73,173
Andreas Pavlides, Md, MD
Cardiovascular Disease — Payments: $67,739
Dr. Adam Levine, D.o, D.O
Cardiovascular Disease — Payments: $62,722
Dr. Vijayendra Verma, Md, MD
Cardiovascular Disease — Payments: $38,237
Dr. Sanford Gips, Md, MD
Cardiovascular Disease — Payments: $25,440